Using the NCCLS agar dilution method, we studied the in vitro activity of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium species, including seven multiresistant strains, and found retapamulin to be the most active agent among those tested with MICs of < or = 1 microg/ml against all isolates.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1346797 | PMC |
| http://dx.doi.org/10.1128/AAC.50.1.379-381.2006 | DOI Listing |
Publication Analysis
Top Keywords
retapamulin sb-275833
8
sb-275833 141
8
141 clinical
8
clinical isolates
8
isolates propionibacterium
8
comparative vitro
4
vitro activities
4
activities retapamulin
4
isolates
4
propionibacterium spp
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!